Mortality from cerebrovascular diseases in China: Exploration of recent and future trends
10.1097/CM9.0000000000002760
- VernacularTitle:Mortality from cerebrovascular diseases in China: Exploration of recent and future trends
- Author:
Bin LV
1
;
Ge SONG
;
Feng JING
;
Mingyu LI
;
Hua ZHOU
;
Wanjun LI
;
Jiacai LIN
;
Shengyuan YU
;
Jun WANG
;
Xiangyu CAO
;
Chenglin TIAN
Author Information
1. Department of Neurology, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China
- Keywords:
Cerebrovascular diseases;
Mortality;
Epidemiology;
Global Burden of Disease;
China;
COVID-19 pandemic
- From:
Chinese Medical Journal
2024;137(5):588-595
- CountryChina
- Language:Chinese
-
Abstract:
Background::Cerebrovascular disease (CVD) ranks among the foremost factors responsible for mortality on a global scale. The mortality patterns of CVDs and temporal trends in China need to be well-illustrated and updated.Methods::We collected mortality data on patients with CVD from Chinese Center for Disease Control and Prevention’s Disease Surveillance Points (CDC-DSP) system. The mortality of CVD in 2020 was described by age, sex, residence, and region. The temporal trend from 2013 to 2019 was evaluated using joinpoint regression, and estimated rates of decline were extrapolated until 2030 using time series models.Results::In 2019, the age-standardized mortality in China (ASMRC) per 100,000 individuals was 113.2. The ASMRC for males (137.7/10 5) and rural areas (123.0/10 5) were both higher when stratified by gender and urban/rural residence. The central region had the highest mortality (126.5/10 5), the western region had a slightly lower mortality (123.5/10 5), and the eastern region had the lowest mortality (97.3/10 5). The age-specific mortality showed an accelerated upward trend from aged 55-59 years, with maximum mortality observed in individuals over 85 years of age. The age-standardized mortality of CVD decreased by 2.43% (95% confidence interval, 1.02-3.81%) annually from 2013 to 2019. Notably, the age-specific mortality of CVD increased from 2013 to 2019 for the age group of over 85 years. In 2020, both the absolute number of CVD cases and the crude mortality of CVD have increased compared to their values in 2019. The estimated total deaths due to CVD were estimated to reach 2.3 million in 2025 and 2.4 million in 2030. Conclusion::The heightened focus on the burden of CVD among males, rural areas, the central and western of China, and individuals aged 75 years and above has emerged as a pivotal determinant in further decreasing mortalities, consequently presenting novel challenges to strategies for disease prevention and control.
